Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 7/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | UGT2B7 | P16662 | 1/20 | 0.38 |
| ▸ | LPL | P06858 | 1/20 | 0.37 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.37 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | CES2 | O00748 | 1/20 | 0.35 |
| ▸ | CES1 | P23141 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29450253 | 1.00 | CYP2A6 (0.44) | CYP2A6TDP1CYP1A2CA1CA2 | |
| SCHEMBL30047516 | 1.00 | CYP2A6 (0.44) | CYP2A6TDP1CYP1A2CA1CA2 | |
| SCHEMBL28906946 | 1.00 | CYP2A6 (0.44) | CYP2A6TDP1CYP1A2CA1CA2 | |
| SCHEMBL15109051 | 1.00 | CYP2A6 (0.44) | CYP2A6TDP1CYP1A2CA1CA2 | |
| SCHEMBL12748739 | 0.81 | CYP2A6 (0.48) | CYP2A6TDP1CYP1A2CA1CA2 | |
| SCHEMBL246506 | 0.81 | CYP2A6 (0.48) | CYP2A6TDP1CYP1A2CA1CA2 | |
| SCHEMBL29404511 | 0.81 | CYP2A6 (0.48) | CYP2A6TDP1CYP1A2CA1CA2 | |
| SCHEMBL2785643 | 0.81 | CYP2A6 (0.42) | CYP2A6TDP1CYP1A2CA1CA2 | |
| SCHEMBL16288483 | 0.80 | CYP1A2 (0.56) | CYP2A6TDP1CYP1A2ALDH1A1HSD17B10 | |
| SCHEMBL16288482 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115044566-B | Cyclohexanone monooxygenase mutant and application thereof | 江南大学 | 2023-05-02 | — | — | CN | claimed |
| CN-115044566-A | Cyclohexanone monooxygenase mutant and application thereof | 江南大学 | 2022-09-13 | — | — | CN | claimed |
| CN-117486662-A | Method for synthesizing sulfoxide compound by heterogeneous catalysis | 成都理工大学 | 2024-02-02 | — | — | CN | disclosed |
| WO-2023115327-A1 | PYRIDO RING COMPOUND, PREPARATION METHOD THEREFOR, INTERMEDIATE, COMPOSITION, AND APPLICATION | 中国药科大学 | 2023-06-29 | — | — | WO | disclosed |
| CN-115305243-B | Baeyer-Villiger monooxygenase mutant and application thereof | 江南大学 | 2023-06-02 | — | — | CN | disclosed |
| CN-115044566-B | Cyclohexanone monooxygenase mutant and application thereof | 江南大学 | 2023-05-02 | — | — | CN | disclosed |
| CN-115305243-A | Baeyer-Villiger monooxygenase mutant and application thereof | 江南大学 | 2022-11-08 | — | — | CN | disclosed |
| CN-115044566-A | Cyclohexanone monooxygenase mutant and application thereof | 江南大学 | 2022-09-13 | — | — | CN | disclosed |
| WO-2018065611-A1 | 2-AMINO-N-(ARYLSULFINYL)-ACETAMIDE COMPOUNDS AS INHIBITORS OF BACTERIAL AMINOACYL-TRNA SYNTHETASE | Oxford Drug Design Limited (GB) | 2018-04-12 | — | — | WO | disclosed |
| US-20090163723-A1 | METHOD FOR PRODUCING SULFONIUM FLUORINATED ALKYLFLUOROPHOSPHATE | SAN-APRO LIMITED (JP) | 2009-06-25 | — | — | US | disclosed |
| EP-1953139-A1 | METHOD FOR PRODUCING FLUORINATED SULFONIUM ALKYLFLUOROPHOSPHATE | San-Apro Ltd. (JP) | 2008-08-06 | — | — | EP | disclosed |
| US-3987191-A | (ORGANOSULFINYLMETHYL)TRI-ORGANOTIN ACARICIDAL COMPOSITIONS AND METHODS OF USE | THE PROCTER & GAMBLE COMPANY (US) | 1976-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090163723-A1 | METHOD FOR PRODUCING SULFONIUM FLUORINATED ALKYLFLUOROPHOSPHATE | ARSA, SCO2, DOHH | CYP2A6 563/4885TDP1 4043/4885CYP1A2 583/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.